20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LORAZEPAM USP, with a corresponding US DMF Number 22460.
Remarkably, this DMF maintains an Active status since its submission on January 23, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2013, and payment made on September 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II